IRD
Opus Genetics, Inc.
NASDAQ: IRD · HEALTHCARE · BIOTECHNOLOGY
$4.99
-6.90% today
Updated 2026-05-08
Market cap
$356.30M
P/E ratio
—
P/S ratio
25.10x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $6
Volume
0.9M
Opus Genetics, Inc. (IRD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $1.78M | $17.68M | $26.08M | $48.99M | $53.95M | $36.86M |
| Cash & equivalents | $1.54M | $16.40M | $24.53M | $42.63M | $50.50M | $30.32M |
| Current assets | $1.76M | $17.67M | $26.07M | $48.99M | $53.95M | $36.61M |
| Total liabilities | $9.34M | $31.15M | $3.85M | $2.75M | $4.04M | $30.14M |
| Current liabilities | $9.34M | $3.19M | $3.85M | $2.75M | $4.04M | $11.29M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $-7.56M | $-13.47M | $22.22M | $46.24M | $49.91M | $6.72M |
| Retained earnings | $-8.05M | $-32.67M | $-89.37M | $-71.48M | $-81.47M | $-139.00M |
| Accounts receivable | $125000.00 | — | $0.00 | $4.85M | $2.33M | $5.77M |
| Inventory | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — |